Rosetta Genomics Ltd.
ROSG
ROSG was delisted on the 21st of May, 2018.
16 hedge funds and large institutions have $887K invested in Rosetta Genomics Ltd. in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
14% more funds holding
Funds holding: 14 → 16 (+2)
46% less capital invested
Capital invested by funds: $1.65M → $887K (-$758K)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
87% less call options, than puts
Call options by funds: $5K | Put options by funds: $39K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
+$44.6K |
| 2 |
SIM
Spark Investment Management
New York
|
+$32.5K |
| 3 |
HCM
Highlander Capital Management
Short Hills,
New Jersey
|
+$25.7K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$8.96K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$363K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$101K |
| 3 |
Renaissance Technologies
New York
|
-$65K |
| 4 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$37.4K |
| 5 |
Goldman Sachs
New York
|
-$22.3K |
ROSG Hedge Fund Activity: Q4 2014 in Review
16 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Rosetta Genomics Ltd. (ROSG) for Q4 2014, worth a combined $887K — down 46% from $1.65M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ROSG positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was A.R.T. Advisors, opening a new position worth an estimated $44.6K. The largest seller was Wells Fargo, cutting an estimated $363K.
- 16 institutional investors held Rosetta Genomics Ltd. (ROSG) as of Q4 2014, up from 14 in Q3 2014.
- Funds reported $887K of Rosetta Genomics Ltd. stock for Q4 2014, down 46% quarter-over-quarter.
- 5 funds opened new Rosetta Genomics Ltd. positions in Q4 2014 and 2 closed out, a net change of +3 holders.
- The largest Rosetta Genomics Ltd. buyer in Q4 2014 was A.R.T. Advisors, an estimated $44.6K added.
- The largest Rosetta Genomics Ltd. seller in Q4 2014 was Wells Fargo, an estimated $363K sold.
Based on aggregated 13F filings for Q4 2014.